Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors (Q73566974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

N Holler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Kataoka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J L Bodmer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Romero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Romero

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D Deperthes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Engel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Tschopp

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

Journal of Immunological Methods

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

159-173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

CD40 ligand is required for protective cell-mediated immunity to Leishmania major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Immunoadhesins: principles and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Tumor Necrosis Factor (TNF) α quantification by ELISA and bioassay: effects of TNFα-soluble TNF receptor (p55) complex dissociation during assay incubations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Metalloproteinase-mediated release of human Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Characterization of Fas (Apo-1, CD95)-Fas ligand interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Fas ligand in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

"Peptabody": a new type of high avidity binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Functions of CD40 on B cells, dendritic cells and other cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

The pathophysiology of tumor necrosis factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Heteronuclear NMR assignments and secondary structure of the coiled coil trimerization domain from cartilage matrix protein in oxidized and reduced forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Characterization of structural domains of human osteoclastogenesis inhibitory factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Induction of apoptosis in mature T cells by tumour necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

Functions of CD40 and its ligand, gp39 (CD40L).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900239-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-1759(99)00239-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10725460%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference